Совместимость Мульти-табс® Перинатал и Эквамер®
Страница описания препарата Мульти-табс® Перинатал
Страница описания препарата Эквамер®
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system)
Am J Cardiol /Volume:99 Part:3/Feb 1 Page:379-81 / 2007
Case of the month: February 1999--54 year old man with severe muscle weakness
Brain Pathol /Volume:9 Part:3/Jul Page:607-8 / 1999
Safety and tolerability of prolonged-release nicotinic acid combined with a statin in NAUTILUS.
Br J Cardiol /Volume:13 Part:4/Jul-Aug Page:273-277 / 2006
Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy
Drug Saf /Volume:28 Part:3 Page:263-75 / 2005
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатные издания
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure
BMJ /Volume:297 Part:6652/Oct 1 Page:830-2 / 1988
Combined therapy with captopril and potassium supplementation. A potential for hyperkalemia
Arch Intern Med /Volume:144 Part:12/Dec Page:2371-2 / 1984
Severe hyperkalaemia due to the concomitant use of salt substitutes and ACE inhibitors in hypertension: a potentially life threatening interaction
J Hum Hypertens /Volume:13 Part:10/Oct Page:717-20 / 1999
Haemodynamic, hormonal, and electrolyte responses to captopril in resistant heart failure
Lancet /Volume:1 Part:8211/Jan 10 Page:71-4 / 1981
Cтепень серьёзности/тяжести
Достоверность
Описание взаимодействия
Источники
Печатное издание
The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics
Curr Med Res Opin /Volume:24 Part:4/Apr Page:1231-5 / 2008